血友病患者的肩关节置换术
Shoulder Arthroplasty in Hemophilia.
作者信息
Rodriguez-Merchan E Carlos, De la Corte-Rodriguez Hortensia, Antuña Samuel, Gomez-Cardero Primitivo, Alvarez-Roman M Teresa, Jimenez-Yuste Victor
机构信息
Department of Orthopedic Surgery, La Paz University Hospital, Madrid, Spain.
Department of Physical and Rehabilitation Medicine, La Paz University Hospital, Madrid, Spain.
出版信息
Arch Bone Jt Surg. 2025;13(3):164-169. doi: 10.22038/ABJS.2024.80320.3667.
The aim of this article is to perform a review of the literature on the current status of shoulder arthroplasty in people with hemophilia (PWH). A search was conducted in PubMed on December 8, 2024, using the keywords "hemophilia" and "shoulder arthroplasty." To date only 4 articles (84 shoulder arthroplasties) in PWH have been published. A recent study with level 3 of evidence has found that five-year implant survival was similar in PWH (97.3%) than in matched controls (95.2%) suggesting that total shoulder arthroplasty (TSA) survivorship endures lasting and might be proposed to PWH. However, the high risks of both 90-day bleeding complication and venous thromboembolism (VTE) in PWH stressed the special dares of scrupulously weighing factor replacement and VTE prophylaxis pre-, intra-, and postoperatively on an individual patient basis with cautious hematologist coordination.
本文旨在对血友病患者（PWH）肩关节置换术的现状进行文献综述。2024年12月8日在PubMed上进行了搜索，使用关键词“血友病”和“肩关节置换术”。迄今为止，仅发表了4篇关于PWH的文章（84例肩关节置换术）。一项证据等级为3的近期研究发现，PWH的五年植入物存活率（97.3%）与匹配对照组（95.2%）相似，这表明全肩关节置换术（TSA）的生存率持久，可能适用于PWH。然而，PWH发生90天出血并发症和静脉血栓栓塞（VTE）的高风险强调了在血液科医生谨慎协作的基础上，针对个体患者在术前、术中和术后严格权衡因子替代和VTE预防的特殊挑战。
Zotero 插件